Data Requirements for Patenting Biotech/Pharma Inventions in China and the EU

In Webinars

1 July, 2020

This interactive webinar considers the filing and post-filing data requirements for biotechnology and pharmaceutical-related inventions in China and the EU. Xiaofan Chen, Hai Liu and Helle Friis Svenstrup from AWA’s Asian and European offices explain the minimum data requirements during filing and also the criteria for supplementary data. They also consider the use of post-grant data as evidence during invalidation proceedings. Understanding the differences between the European and Chinese regimes is essential for applicants to be successful.

 

 

 

You may also be interested in:

Bad news for WhatsApp as Norwegian Board of Appeal refuses to register logo

With a reported total of more than 500 million users globally, many of us will have used or at

Read more...

The Busines of IP – Understanding and Creating Value: Part 1 – Venture Capital

In this six-part series, Anders Isaksson explores some of the key factors and motivators for why companies small or

Read more...

Protecting Biological Drug Innovations

  Learn how to protect biological drug innovations during this webinar from Stockholm Science City (In Swedish). Ulrika Munter and Nora Spjuth share their experiences

Read more...

Mobile Sliding Menu